These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27933411)

  • 1. Society of Surgical Oncology Breast Disease Working Group Statement on Prophylactic (Risk-Reducing) Mastectomy.
    Hunt KK; Euhus DM; Boughey JC; Chagpar AB; Feldman SM; Hansen NM; Kulkarni SA; McCready DR; Mamounas EP; Wilke LG; Van Zee KJ; Morrow M
    Ann Surg Oncol; 2017 Feb; 24(2):375-397. PubMed ID: 27933411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should the use of contralateral prophylactic mastectomy be increasing as it is?
    Wood WC
    Breast; 2009 Oct; 18 Suppl 3():S93-5. PubMed ID: 19914552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contralateral Prophylactic Mastectomy: Challenging Considerations for the Surgeon.
    Angelos P; Bedrosian I; Euhus DM; Herrmann VM; Katz SJ; Pusic A
    Ann Surg Oncol; 2015 Oct; 22(10):3208-12. PubMed ID: 26259752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discussions about contralateral prophylactic mastectomy among surgical oncology providers and women with sporadic breast cancer: a content analysis.
    D'Agostino TA; Brewster AM; Peterson SK; Bedrosian I; Parker PA
    Transl Behav Med; 2020 May; 10(2):347-354. PubMed ID: 30561744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The development of a template for psychological assessment of women considering risk-reducing or contralateral prophylactic mastectomy: A national Delphi consensus study.
    Braude L; Kirsten L; Gilchrist J; Juraskova I
    Psychooncology; 2018 Oct; 27(10):2349-2356. PubMed ID: 29966172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Streamlining Decision Making in Contralateral Risk-Reducing Mastectomy: Impact of PREDICT and BOADICEA Computations.
    de Silva TS; Russell VR; Henry FP; Thiruchelvam PTR; Hadjiminas DJ; Al-Mufti R; Hogben RK; Hunter J; Wood S; Jallali N; Leff DR
    Ann Surg Oncol; 2018 Oct; 25(10):3057-3063. PubMed ID: 30019305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of contralateral prophylactic mastectomy and the impact on breast reconstruction.
    Pinell-White XA; Kolegraff K; Carlson GW
    Ann Plast Surg; 2014; 72(6):S153-7. PubMed ID: 24691345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The contralateral prophylactic mastectomy decision-making process.
    Baker SK; Mayer DK; Esposito N
    Plast Surg Nurs; 2013; 33(1):11-21; quiz 22-3. PubMed ID: 23446503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada.
    Squires JE; Simard SN; Asad S; Stacey D; Graham ID; Coughlin M; Clemons M; Grimshaw JM; Zhang J; Caudrelier JM; Arnaout A
    Curr Oncol; 2019 Aug; 26(4):e439-e457. PubMed ID: 31548812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic mastectomy for the prevention of breast cancer.
    Lostumbo L; Carbine N; Wallace J; Ezzo J
    Cochrane Database Syst Rev; 2004 Oct; (4):CD002748. PubMed ID: 15495033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mastectomy for risk reduction or symmetry in women without high risk gene mutation: A review.
    Kenny R; Reed M; Subramanian A
    Int J Surg; 2018 Feb; 50():60-64. PubMed ID: 29288115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is prophylactic mastectomy justified in women without BRCA mutation?
    Rutgers EJT
    Breast; 2019 Nov; 48 Suppl 1():S62-S64. PubMed ID: 31839163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network project.
    Herrinton LJ; Barlow WE; Yu O; Geiger AM; Elmore JG; Barton MB; Harris EL; Rolnick S; Pardee R; Husson G; Macedo A; Fletcher SW
    J Clin Oncol; 2005 Jul; 23(19):4275-86. PubMed ID: 15795415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reframing the conversation about contralateral prophylactic mastectomy: Preparing women for postsurgical realities.
    Bloom DL; Chapman BM; Wheeler SB; McGuire KP; Lee CN; Weinfurt K; Rosenstein DL; Plichta JK; Jacobson Vann JC; Hwang ES
    Psychooncology; 2019 Feb; 28(2):394-400. PubMed ID: 30500102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contralateral risk-reducing mastectomy in young women.
    Merck B
    Breast Cancer Res Treat; 2010 Sep; 123 Suppl 1():29-32. PubMed ID: 20711671
    [No Abstract]   [Full Text] [Related]  

  • 17. Factors associated with decision to undergo contralateral prophylactic mastectomy versus unilateral mastectomy.
    Huang J; Chagpar A
    Am J Surg; 2019 Jul; 218(1):170-174. PubMed ID: 30554666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contralateral prophylactic mastectomy for patients with unilateral breast cancer.
    Tuttle T; Habermann E; Abraham A; Emory T; Virnig B
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1117-22. PubMed ID: 18028020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic mastectomy: who needs it, when and why.
    Burke EE; Portschy PR; Tuttle TM
    J Surg Oncol; 2015 Jan; 111(1):91-5. PubMed ID: 24965368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "It felt like unfinished business, it feels like that's finished now": Women's experiences of decision making around contralateral prophylactic mastectomy (CPM).
    Tollow P; Williams VS; Harcourt D; Paraskeva N
    Psychooncology; 2019 Jun; 28(6):1328-1334. PubMed ID: 30963646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.